Global Lurasidone Hydrochloride Tablets Market Growth 2023-2029

Global Lurasidone Hydrochloride Tablets Market Growth 2023-2029

The global Lurasidone Hydrochloride Tablets market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Lurasidone Hydrochloride Tablets is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Lurasidone Hydrochloride Tablets is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Lurasidone Hydrochloride Tablets is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Lurasidone Hydrochloride Tablets players cover Sunovion, Bushu Pharma, Zhe JIANG HUA HAI Pharmaceutical Co., Ltd., Zhejiang Hisun Pharmaceutical Co., Ltd., Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd., YANGTZE River Pharmaceutical Group Nanjing Pharmaceutical. Co., Ltd. and Jiangsu Hansoh Pharmaceutical Group Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

Lurasidone hydrochloride tablet is an antipsychotic drug that exerts a sedative effect through combined antagonism of central dopamine and serotonin receptors. Mainly used for the treatment of schizophrenia.

LPI (LP Information)' newest research report, the “Lurasidone Hydrochloride Tablets Industry Forecast” looks at past sales and reviews total world Lurasidone Hydrochloride Tablets sales in 2022, providing a comprehensive analysis by region and market sector of projected Lurasidone Hydrochloride Tablets sales for 2023 through 2029. With Lurasidone Hydrochloride Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Lurasidone Hydrochloride Tablets industry.

This Insight Report provides a comprehensive analysis of the global Lurasidone Hydrochloride Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Lurasidone Hydrochloride Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Lurasidone Hydrochloride Tablets market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Lurasidone Hydrochloride Tablets and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Lurasidone Hydrochloride Tablets.

This report presents a comprehensive overview, market shares, and growth opportunities of Lurasidone Hydrochloride Tablets market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
20mg(C₂₈H₃₆N₄O₂S·HCl)
40mg(C₂₈H₃₆N₄O₂S·HCl)

Segmentation by application
Hospital
Retail Pharmacy
Clinic
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Sunovion
Bushu Pharma
Zhe JIANG HUA HAI Pharmaceutical Co., Ltd.
Zhejiang Hisun Pharmaceutical Co., Ltd.
Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd.
YANGTZE River Pharmaceutical Group Nanjing Pharmaceutical. Co., Ltd.
Jiangsu Hansoh Pharmaceutical Group Co., Ltd.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Lurasidone Hydrochloride Tablets market?

What factors are driving Lurasidone Hydrochloride Tablets market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Lurasidone Hydrochloride Tablets market opportunities vary by end market size?

How does Lurasidone Hydrochloride Tablets break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.